NURECA
Back to All Ratios
|
NURECA Last 5 Year EBIT Growth History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EBIT Growth(%) | 224.43 | 80.03 | -116.67 | -3.46 | 581.55 |
What is the latest EBIT Growth ratio of NURECA ?
| Year | EBIT Growth |
|---|---|
| Mar2025 | 224.43 |
| Mar2024 | 80.03 |
| Mar2023 | -116.67 |
| Mar2022 | -3.46 |
| Mar2021 | 581.55 |
How is EBIT Growth of NURECA Trending?
| Years | EBIT Growth | % Change | |
|---|---|---|---|
| Mar2025 | 224.43 | 180.43 | |
| Mar2024 | 80.03 | Positive | |
| Mar2023 | -116.67 | Negative | |
| Mar2022 | -3.46 | Negative | |
| Mar2021 | 581.55 | - | |
Other Financial Ratios of NURECA
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Growth ratio of peers of NURECA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NURECA | ₹302.4 Cr | 32.2% | 32.9% | 8.5% | Stock Analytics | |
| POLY MEDICURE | ₹19,500.1 Cr | 0.2% | -1.8% | -21% | Stock Analytics | |
NURECA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NURECA | 32.2% |
32.9% |
8.5% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses